Characterization and Molecular Mechanism of Aminoglycoside-6-Adenyl Transferase Associated with Aminoglycoside Resistance from Elizabethkingia meningoseptica
Infection and Drug Resistance · 2023-08 · Volume 16 · 5523-5534
DOI: 10.2147/idr.s423418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2023-08. Verfasst von Shaoxing Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
Elizabethkingia meningoseptica (EM) is a multi-drug-resistant bacterium of global concern for its role in nosocomial infection and is generally resistant to aminoglycoside antibiotics. In the whole genome of an EM strain (FMS-007), an aminoglycoside-6-adenyl transferase gene (ant(6)FMS-007) was predicted. This study aimed to characterize the biochemical function of ANT(6)FMS-007 and analyze the relationship between genotype and phenotype of ant(6) in clinical EM isolates, so as to provide evidence for clinical precision drug use. This study could establish a method for the verification of known or unknown functionally resistant genes.
Methods
A total of 42 EM clinical isolates were collected from clinical departments during 2015-2023. The phenotype of aminoglycoside antibiotics was analyzed by broth microdilution (BMD) and Kirby-Bauer (K-B) methods. The whole-length ant(6) from EM clinical isolates was analyzed by polymerase chain reaction (PCR) and sequencing. The biochemical function of predictive ANT(6)FMS-007 from the FMS-007 whole genome was identified by 3D plate experiment and mass spectrometry analysis. Candidate active sites were predicted by multi-species sequence alignment and molecular docking, and other important sites were identified in the comparison of ant(6) genotypes and phenotypes of EM clinical isolates. Drug susceptibility test was used to verify the function of these sites.
Results
The predictive ANT(6)FMS-007 protein could inactivate STR by modifying STR with ATP to form STR-AMP. Four active sites (Asp-38, Asp-42, Lys-95, and Lys-213) of ANT(6)FMS-007 were identified. Thirty-one EM clinical isolates (74%) carried the ant(6) gene. Eight EM clinical isolates containing the ant(6) gene had MIC values (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
- Clinical Laboratory Department, Jiaxing Maternity and Child Health Care Hospital, Jiaxing, Zhejiang, People's Republic of China.
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.
- College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, Shandong, People's Republic of China.
Zitieren
APA
Zhang, S., Zhang, Y., Liu, R., Yuan, S., Chen, Y., Li, W., Lu, X., Tong, Y., Hou, L., Chen, L., & Sun, G. (2023). Characterization and Molecular Mechanism of Aminoglycoside-6-Adenyl Transferase Associated with Aminoglycoside Resistance from Elizabethkingia meningoseptica. Infection and Drug Resistance, Volume 16, 5523-5534. https://doi.org/10.2147/idr.s423418
Vancouver
Zhang S, Zhang Y, Liu R, Yuan S, Chen Y, Li W, et al. Characterization and Molecular Mechanism of Aminoglycoside-6-Adenyl Transferase Associated with Aminoglycoside Resistance from Elizabethkingia meningoseptica. Infection and Drug Resistance. 2023;Volume 16:5523-5534. doi:10.2147/idr.s423418
BibTeX
@article{Zhang2023,
author = {Zhang, Shaoxing and Zhang, Yuxin and Liu, Ruijie and Yuan, Shuying and Chen, Yanwen and Li, Wenjie and Lu, Xinrong and Tong, Yongliang and Hou, Linlin and Chen, Li and Sun, Guiqin},
title = {Characterization and Molecular Mechanism of Aminoglycoside-6-Adenyl Transferase Associated with Aminoglycoside Resistance from Elizabethkingia meningoseptica},
journal = {Infection and Drug Resistance},
year = {2023},
volume = {Volume 16},
pages = {5523--5534},
doi = {10.2147/idr.s423418}
}
EUVIMED